Topically Administered Gold Nanoparticles Inhibit Experimental Corneal Neovascularization in Mice

被引:33
作者
Cho, Won-Kyung [1 ,2 ]
Kang, Seungbum [1 ,2 ]
Choi, Hyunsu [2 ]
Rho, Chang Rae [1 ,2 ]
机构
[1] Catholic Univ Korea, Dept Ophthalmol & Visual Sci, Daejeon St Marys Hosp, Coll Med, Taejon 301723, South Korea
[2] Catholic Univ Korea, Clin Res Inst, Daejeon St Marys Hosp, Coll Med, Taejon 301723, South Korea
关键词
corneal neovascularization; gold nanoparticle; extracellular signal-regulated kinase; vascular endothelial growth factor receptor 2; ENDOTHELIAL-CELLS; GROWTH-FACTOR; BEVACIZUMAB; PATHWAYS;
D O I
10.1097/ICO.0000000000000343
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: The aim of this study was to evaluate the in vivo effects and mechanism of topically administered gold nanoparticles (AuNP) in a mouse model of corneal neovascularization. Methods: Inflammatory corneal neovascularization was induced by alkali burns, and the corneas were treated with topical AuNPs. After 1 week, the area of corneal neovascularization was measured using image analysis. The levels of vascular endothelial growth factor receptor 2 and extracellular signal-regulated kinase (ERK1/2) were evaluated by Western blotting. Results: The area of corneal neovascularization was significantly reduced by 39.8% in the AuNP group compared with the control group (P = 0.002). Corneal vascular endothelial growth factor receptor 2 level was higher in the control group than in the AuNP-treated group (P = 0.029). AuNP treatment similarly inhibited burn-induced phosphorylation of ERK (P = 0.029). Conclusions: Topical administration of AuNPs significantly reduced development of inflammatory corneal neovascularization by inhibiting the ERK pathway.
引用
收藏
页码:456 / 459
页数:4
相关论文
共 18 条
[1]   Mechanism of anti-angiogenic property of gold nanoparticles: role of nanoparticle size and surface charge [J].
Arvizo, Rochelle R. ;
Rana, Subinoy ;
Miranda, Oscar R. ;
Bhattacharya, Resham ;
Rotello, Vincent M. ;
Mukherjee, Priyabrata .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2011, 7 (05) :580-587
[2]  
Azar Dimitri T, 2006, Trans Am Ophthalmol Soc, V104, P264
[3]   Kringle domains of human angiostatin - Characterization of the anti-proliferative activity on endothelial cells [J].
Cao, YH ;
Ji, RW ;
Davidson, D ;
Schaller, J ;
Marti, D ;
Sohndel, S ;
McCance, SG ;
OReilly, MS ;
Llinas, M ;
Folkman, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (46) :29461-29467
[4]   KR-31378, a Potassium-Channel Opener, Induces the Protection of Retinal Ganglion Cells in Rat Retinal Ischemic Models [J].
Choi, Anho ;
Choi, Jun-Sub ;
Yoon, Yone-Jung ;
Kim, Kyung-A ;
Joo, Choun-Ki .
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 (04) :511-517
[5]   Novel aspects of corneal angiogenic and lymphangiogenic privilege [J].
Ellenberg, David ;
Azar, Dimitri T. ;
Hallak, Joelle A. ;
Tobaigy, Faisal ;
Han, Kyu Yeon ;
Jain, Sandeep ;
Zhou, Zhongjun ;
Chang, Jin-Hong .
PROGRESS IN RETINAL AND EYE RESEARCH, 2010, 29 (03) :208-248
[6]   Subconjunctival bevacizumab for corneal neovascularization [J].
Erdurmus, Mesut ;
Totan, Yuksel .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2007, 245 (10) :1577-1579
[7]   PREVENTION OF CORNEAL VASCULARIZATION [J].
EY, RC ;
HUGHES, WF ;
BLOOME, MA ;
TALLMAN, CB .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1968, 66 (06) :1118-&
[8]   Opinion - Angiogenesis: an organizing principle for drug discovery? [J].
Folkman, Judah .
NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (04) :273-286
[9]   Gold Nanoparticles for Biology and Medicine [J].
Giljohann, David A. ;
Seferos, Dwight S. ;
Daniel, Weston L. ;
Massich, Matthew D. ;
Patel, Pinal C. ;
Mirkin, Chad A. .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2010, 49 (19) :3280-3294
[10]   The inhibition of retinal neovascularization by gold nanoparticles via suppression of VEGFR-2 activation [J].
Kim, Jin Hyoung ;
Kim, Myung Hun ;
Jo, Dong Hyun ;
Yu, Young Suk ;
Lee, Tae Geol ;
Kim, Jeong Hun .
BIOMATERIALS, 2011, 32 (07) :1865-1871